Global Artificial Intelligence Protein Design Service Market Growth (Status and Outlook) 2026-2032

The global Artificial Intelligence Protein Design Service market size is predicted to grow from US$ 1941 million in 2025 to US$ 5754 million in 2032; it is expected to grow at a CAGR of 17.1% from 2026 to 2032.

Artificial intelligence protein design service is a service that uses machine learning, deep learning and generative artificial intelligence technology, combined with biological big data, to optimize or create protein structure and function. This service significantly improves the efficiency of protein engineering by accurately predicting the three-dimensional structure of proteins, analyzing sequence and function relationships, and generating new protein sequences. It is widely used in drug research and development, enzyme engineering, gene therapy, and industrial biotechnology to help accelerate biomedicine and synthesis. Innovations in Biology.

United States market for Artificial Intelligence Protein Design Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Artificial Intelligence Protein Design Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Artificial Intelligence Protein Design Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Artificial Intelligence Protein Design Service players cover DeepMind, Generate Biomedicines, Insitro, Arzeda, Atomwise, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Artificial Intelligence Protein Design Service Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Protein Design Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Protein Design Service sales for 2026 through 2032. With Artificial Intelligence Protein Design Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Protein Design Service industry.

This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Protein Design Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Protein Design Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Protein Design Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Protein Design Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Protein Design Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Protein Design Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Protein Prediction Service
Protein Generation Service

Segmentation by Application:
Pharmaceutical Industry
Agriculture
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
DeepMind
Generate Biomedicines
Insitro
Arzeda
Atomwise
BioMap
Nebula Genomics
Insilico Medicine

Please note: The report will take approximately 2 business days to prepare and deliver. Show more